1. Home
  2. Analysis
  3. Cefazolin-sodium
  4. Weight-abnormal

Cefazolin sodium and Weight abnormal - a phase IV clinical study of FDA data

Summary:

Weight abnormal is reported as a side effect among people who take Cefazolin sodium (cefazolin sodium), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Aranesp, and have Colon cancer.

The phase IV clinical study analyzes which people have Weight abnormal when taking Cefazolin sodium. It is created by eHealthMe based on reports of 3,643 people who have side effects when taking Cefazolin sodium from the FDA, and is updated regularly.

What is Cefazolin sodium?

Cefazolin sodium has active ingredients of cefazolin sodium. eHealthMe is studying from 3,649 Cefazolin sodium users. Check the latest studies of Cefazolin sodium.

What is Weight abnormal?

Weight abnormal is found to be associated with 1,610 drugs and 1,300 conditions by eHealthMe. Check the latest studies of Weight abnormal.

On Jul, 24, 2026

3,643 people reported to have side effects when taking Cefazolin sodium.
Among them, 12 people (0.33%) have Weight abnormal.

Could Cefazolin sodium cause Weight abnormal?

Among these 12 people:

How long have people been on Cefazolin sodium when they have Weight abnormal? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Weight abnormal when taking Cefazolin sodium? *

  • female: 83.33 %
  • male: 16.67 %

What is the age of people who have Weight abnormal when taking Cefazolin sodium? *

  • 0-1: 0.0 %
  • 2-9: 8.33 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 83.33 %
  • 60+: 8.33 %

What are other drugs people take besides Cefazolin sodium? *

  1. Lasix: 11 people, 91.67%
  2. Aranesp: 11 people, 91.67%
  3. Fentanyl Citrate: 10 people, 83.33%
  4. Lortab: 10 people, 83.33%
  5. Lisinopril: 10 people, 83.33%
  6. Zometa: 10 people, 83.33%
  7. Keppra: 10 people, 83.33%
  8. Keflex: 10 people, 83.33%
  9. Flexeril: 10 people, 83.33%
  10. Famotidine: 10 people, 83.33%

What are other side effects people have besides Weight abnormal? *

  1. Oedema Peripheral (superficial swelling): 11 people, 91.67%
  2. Cardiac Failure Congestive: 11 people, 91.67%
  3. Back Pain: 11 people, 91.67%
  4. Thrombocytopenia (decrease of platelets in blood): 11 people, 91.67%
  5. High Blood Pressure: 11 people, 91.67%
  6. Stress And Anxiety: 11 people, 91.67%
  7. Infection: 10 people, 83.33%
  8. Bone Deformity: 10 people, 83.33%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 83.33%
  10. Haematoma (collection of blood outside the blood vessels): 10 people, 83.33%

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 1 person, 8.33%
  2. Colon Cancer: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin sodium and have Weight abnormal?

- Check whether Weight abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefazolin sodium:

Weight abnormal treatments and more:

How severe was Weight abnormal and when was it recovered:

Expand to all the drugs that have ingredients of cefazolin sodium:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weight abnormal:

Browse all the conditions that are associated with Weight abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium (the active ingredients of Cefazolin sodium) and Cefazolin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.